FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

RLS Foundation Takes on Consumer Reports

[ Price : $8.95]

The Restless Leg Syndrome Foundation calls on its members and supporters to cancel subscriptions to Consumer Reports after the mag...

Woodcock Praises Reagan-Udall Foundation

[ Price : $8.95]

FDA chief medical officer Janet Woodcock, says the controversial Reagan-Udall Foundation may provide important support for applied...

FDA OKs Nexavar for Liver Cancer

[ Price : $8.95]

FDA approves a Bayer HealthCare and Onyx Pharmaceuticals NDA for Nexavar (sorafenib) tablets, indicated for treating patients with...

FDA Wants Another Trial for Huntingtons Drug

[ Price : $8.95]

FDA asks Amarin Corp. to conduct an additional Phase 3 clinical trial to provide confirmatory evidence on its investigational drug...

FDA Vows Follow-up to Risky Devices Expos

[ Price : $8.95]

CDRH compliance director Tim Ulatowski says FDA is investigating reports of flagrant marketing of illegal and dangerous medical de...

Gottlieb: FDA Unprepared for Follow-on Biologics

[ Price : $8.95]

Former FDA deputy commissioner for medical and scientific affairs Scott Gottlieb says organizational changes are needed at FDA to ...

FDA Seizes Dangerous Eyelash Cosmetic

[ Price : $8.95]

FDA orders the seizure of Jan Marini Skin Researchs Age Intervention Eyelash in San Jose as an unapproved and misbranded drug that...

Learned Intermediary Rule Out in WV

[ Price : $8.95]

American Enterprise Institute fellow Ted Frank says there are many reasons why the West Virginia Supreme Court erred in throwing o...

CDRH Consensus Standard Guidances

[ Price : $8.95]

CDRH issues three guidances on using consensus standards to satisfy premarket review requirements.

FDA OKs Seroquel Expanded Use

[ Price : $8.95]

FDA approves an AstraZeneca supplemental NDA for Seroquel XR (quetiapine fumarate) and its expanded use as maintenance treatment i...